375 related articles for article (PubMed ID: 20858214)
1. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
Jana S; Mandlekar S; Marathe P
Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
[TBL] [Abstract][Full Text] [Related]
2. Is prodrug design an approach to increase water solubility?
Sanches BMA; Ferreira EI
Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs: a challenge for the drug development.
Zawilska JB; Wojcieszak J; Olejniczak AB
Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
[TBL] [Abstract][Full Text] [Related]
4. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
5. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
6. Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption.
Rumondor ACF; Dhareshwar SS; Kesisoglou F
J Pharm Sci; 2016 Sep; 105(9):2498-2508. PubMed ID: 26886316
[TBL] [Abstract][Full Text] [Related]
7. Advances in the use of prodrugs for drug delivery to the eye.
Taskar P; Tatke A; Majumdar S
Expert Opin Drug Deliv; 2017 Jan; 14(1):49-63. PubMed ID: 27441817
[TBL] [Abstract][Full Text] [Related]
8. Prodrug strategies to overcome poor water solubility.
Stella VJ; Nti-Addae KW
Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
[TBL] [Abstract][Full Text] [Related]
9. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist.
Beaumont K; Webster R; Gardner I; Dack K
Curr Drug Metab; 2003 Dec; 4(6):461-85. PubMed ID: 14683475
[TBL] [Abstract][Full Text] [Related]
10. [Research of oral prodrugs: opportunities and challenges].
Cao F; Ping QN; Chen J
Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
[TBL] [Abstract][Full Text] [Related]
11. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.
Majumdar S; Duvvuri S; Mitra AK
Adv Drug Deliv Rev; 2004 Jun; 56(10):1437-52. PubMed ID: 15191791
[TBL] [Abstract][Full Text] [Related]
12. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.
Dahan A; Khamis M; Agbaria R; Karaman R
Expert Opin Drug Deliv; 2012 Aug; 9(8):1001-13. PubMed ID: 22703376
[TBL] [Abstract][Full Text] [Related]
13. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
[TBL] [Abstract][Full Text] [Related]
14. Prodrug strategy for enhancing drug delivery via skin.
Fang JY; Leu YL
Curr Drug Discov Technol; 2006 Sep; 3(3):211-24. PubMed ID: 17311566
[TBL] [Abstract][Full Text] [Related]
15. Lipidic prodrug approach for improved oral drug delivery and therapy.
Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.
A M Subbaiah M; Mandlekar S; Desikan S; Ramar T; Subramani L; Annadurai M; Desai SD; Sinha S; Jenkins SM; Krystal MR; Subramanian M; Sridhar S; Padmanabhan S; Bhutani P; Arla R; Singh S; Sinha J; Thakur M; Kadow JF; Meanwell NA
J Med Chem; 2019 Apr; 62(7):3553-3574. PubMed ID: 30938524
[TBL] [Abstract][Full Text] [Related]
17. Modern prodrug design for targeted oral drug delivery.
Dahan A; Zimmermann EM; Ben-Shabat S
Molecules; 2014 Oct; 19(10):16489-505. PubMed ID: 25317578
[TBL] [Abstract][Full Text] [Related]
18. The use of esters as prodrugs for oral delivery of beta-lactam antibiotics.
Mizen L; Burton G
Pharm Biotechnol; 1998; 11():345-65. PubMed ID: 9760687
[TBL] [Abstract][Full Text] [Related]
19. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl-peptidase IV (DPP IV/CD26)-activated prodrugs: a successful strategy for improving water solubility and oral bioavailability.
Velázquez S; de Castro S; Diez-Torrubia A; Balzarini J; Camarasa MJ
Curr Med Chem; 2015; 22(8):1041-54. PubMed ID: 25620096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]